Similarly, NK cells and CD8+ T cells have been recently shown to trigger tumor clearance via the GSDMB-granzyme A axis (12), and higher enrichment of NK and CD8+ T cells usually reflects better ICB efficacy (85). This evidence concerns the gene CD8A and neoplasm.